{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:28:51Z","timestamp":1794745731382,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yunnan Xingdian Talent Support Plan - \u201cFamous Doctor\u201d special Project","award":["RLMY2020007"],"award-info":[{"award-number":["RLMY2020007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The global incidence of Hyperphenylalaninemia (HPA) demonstrates significant geographical variations, exhibiting distinct regional and ethnic characteristics in both phenotypic manifestations and genotypic profiles. To date, there remains a paucity of data regarding the genotype-phenotype correlation in pediatric patients with phenylalanine hydroxylase deficiency (PAHD) from Southwest China. This study aims to conduct a retrospective analysis of neonatal HPA prevalence and characterize\n                      <jats:italic>PAH<\/jats:italic>\n                      gene mutations in Yunnan Province in Southwest China. These findings are expected to establish an evidence base for optimizing clinical follow-up protocols, facilitating genetic counseling, and enabling prenatal molecular diagnosis for affected children.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From January 2013 to December 2023, neonatal screening data for HPA were retrospectively collected from the Yunnan Neonatal Screening Center. Neonates with presumptive positive screening results underwent confirmatory diagnosis through quantitative analysis of phenylalanine levels using tandem mass spectrometry. Subsequently, HPA-related genetic variants were identified by next-generation sequencing technology. Putative pathogenic mutations detected in probands were validated through Sanger sequencing of trios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,261,043 newborn screening samples for phenylalanine were analyzed, with 125 cases confirmed as HPA. The overall incidence rates were 0.99 per 10,000 for HPA, 0.98 per 10,000 for PAHD, and 0.16 per 100,000 for tetrahydrobiopterin deficiency. Genetic analysis of hyperphenylalaninemia-related genes was performed in 84 children, revealing 49\n                      <jats:italic>PAH<\/jats:italic>\n                      variants, 2\n                      <jats:italic>PTS<\/jats:italic>\n                      variants, and 1\n                      <jats:italic>QDPR<\/jats:italic>\n                      variant, with a total of 164 mutation sites identified. Missense mutations constituted the predominant variant type. The most frequent\n                      <jats:italic>PAH<\/jats:italic>\n                      mutations were c.728G\u2009&gt;\u2009A\/p.R243Q (26.88%), c.331C\u2009&gt;\u2009T\/p.R111* (9.38%), c.320A\u2009&gt;\u2009G\/p.H107R (8.13%), c.158G\u2009&gt;\u2009A\/p.A53H (7.50%), and c.441\u2009+\u20092T\u2009&gt;\u2009A\/splicing (5.00%), with clustering observed in exons 7, 11, 6, and 3. A novel\n                      <jats:italic>PAH<\/jats:italic>\n                      mutation (c.60\u2009+\u20094A\u2009&gt;\u2009G\/ p.?.) was identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The incidence and genetic mutation spectrum of HPA in Yunnan Province, Southwest China, exhibit distinctive characteristics when compared with other regions in China and international reports. These differences may be attributed to the unique geographical distribution of HPA patients and ethnic-specific genetic characteristics in this region. Furthermore, specific genetic mutations demonstrate potential associations with clinical phenotypes in PAHD. The novel\n                      <jats:italic>PAH<\/jats:italic>\n                      mutations identified in this study have expanded the current\n                      <jats:italic>PAH<\/jats:italic>\n                      gene database.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04114-3","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:02:23Z","timestamp":1764072143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The incidence rate and gene mutation characteristics of hyperphenylalaninemia in Yunnan Province, Southwest China"],"prefix":"10.1186","volume":"20","author":[{"given":"Qiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-2275","authenticated-orcid":false,"given":"Zhiye","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"4114_CR1","doi-asserted-by":"crossref","unstructured":"Blau N, Hennermann JB, Langenbeck U. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab. 2011;104(Suppl):S2\u20139.","DOI":"10.1016\/j.ymgme.2011.08.017"},{"issue":"2","key":"4114_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188\u2013200.","journal-title":"GENET MED"},{"issue":"4","key":"4114_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00894-015-2620-6","volume":"21","author":"K Reblova","year":"2015","unstructured":"Reblova K, Kulhanek P, Fajkusova L. Computational study of missense mutations in phenylalanine hydroxylase. J Mol Model. 2015;21(4):70.","journal-title":"J MOL MODEL"},{"issue":"1","key":"4114_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","volume":"15","author":"T Opladen","year":"2020","unstructured":"Opladen T, Lopez-Laso E, Cortes-Saladelafont E. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies. Orphanet J Rare Dis. 2020;15(1):126.","journal-title":"ORPHANET J RARE DIS"},{"issue":"6","key":"4114_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10545-012-9506-x","volume":"35","author":"T Opladen","year":"2012","unstructured":"Opladen T, Hoffmann GF, Blau N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis. 2012;35(6):963\u201373.","journal-title":"J INHERIT METAB DIS"},{"key":"4114_CR6","doi-asserted-by":"crossref","unstructured":"Trampuz D, Schielen PCJI, Zetterstrom RH. International survey on phenylketonuria newborn screening. Int J Neonat Screen 2025;11(1).","DOI":"10.3390\/ijns11010018"},{"issue":"1","key":"4114_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13023-021-01874-6","volume":"16","author":"PK Foreman","year":"2021","unstructured":"Foreman PK, Margulis AV, Alexander K. Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis. Orphanet J Rare Dis. 2021;16(1):253.","journal-title":"ORPHANET J RARE DIS"},{"issue":"8","key":"4114_CR8","doi-asserted-by":"publisher","first-page":"e31474","DOI":"10.1136\/bmjopen-2019-031474","volume":"9","author":"L Xiang","year":"2019","unstructured":"Xiang L, Tao J, Deng K. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study. Bmj Open. 2019;9(8):e31474.","journal-title":"BMJ OPEN"},{"issue":"1","key":"4114_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1186\/s12887-024-05140-z","volume":"24","author":"AS Aguirre","year":"2024","unstructured":"Aguirre AS, Haro E, Campodonico A. Expanding diversity within phenylketonuria in Ecuadorian patients: genetic analysis and literature review of newborn screenings. BMC Pediatr. 2024;24(1):739.","journal-title":"BMC PEDIATR"},{"issue":"1","key":"4114_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-021-01846-w","volume":"16","author":"X Wang","year":"2021","unstructured":"Wang X, Wang Y, Ma D. Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population. Orphanet J Rare Dis. 2021;16(1):214.","journal-title":"ORPHANET J RARE DIS"},{"issue":"5","key":"4114_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1515\/jpem-2022-0047","volume":"35","author":"M Cinar","year":"2022","unstructured":"Cinar M, Kilic YG, Kocagil S. Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey. J Pediatr Endocr Met. 2022;35(5):639\u201347.","journal-title":"J PEDIATR ENDOCR MET"},{"issue":"2","key":"4114_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","volume":"107","author":"A Hillert","year":"2020","unstructured":"Hillert A, Anikster Y, Belanger-Quintana A. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234\u201350.","journal-title":"AM J HUM GENET"},{"key":"4114_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cca.2018.02.035","volume":"481","author":"R Wang","year":"2018","unstructured":"Wang R, Shen N, Ye J. Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population. Clin Chim Acta. 2018;481:132\u20138.","journal-title":"CLIN CHIM ACTA"},{"issue":"1","key":"4114_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12881-017-0467-7","volume":"18","author":"N Liu","year":"2017","unstructured":"Liu N, Huang Q, Li Q. Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from Northern China. BMC Med Genet. 2017;18(1):108.","journal-title":"BMC MED GENET"},{"issue":"6","key":"4114_CR15","first-page":"420","volume":"52","author":"Y Yang","year":"2014","unstructured":"Yang Y, Ye Y. Consensus about the diagnosis and treatment of hyperphenylalaninemia. Zhonghua Er Ke Za Zhi. 2014;52(6):420\u20135.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"4114_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"GENET MED"},{"issue":"1","key":"4114_CR17","doi-asserted-by":"publisher","first-page":"17137","DOI":"10.1038\/s41598-018-35373-9","volume":"8","author":"T Chen","year":"2018","unstructured":"Chen T, Xu W, Wu D. Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province, China. Sci Rep-Uk. 2018;8(1):17137.","journal-title":"SCI REP-UK"},{"issue":"1","key":"4114_CR18","doi-asserted-by":"publisher","first-page":"11251","DOI":"10.1038\/s41598-018-29640-y","volume":"8","author":"N Li","year":"2018","unstructured":"Li N, He C, Li J. Analysis of the genotype-phenotype correlation in patients with phenylketonuria in Mainland China. Sci Rep-Uk. 2018;8(1):11251.","journal-title":"SCI REP-UK"},{"issue":"3","key":"4114_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1203\/PDR.0b013e3181c9fb85","volume":"67","author":"T Zhu","year":"2010","unstructured":"Zhu T, Qin S, Ye J. Mutational spectrum of phenylketonuria in the Chinese Han population: a novel insight into the geographic distribution of the common mutations. Pediatr Res. 2010;67(3):280\u20135.","journal-title":"PEDIATR RES"},{"issue":"3","key":"4114_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/00365513.2018.1434898","volume":"78","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Gao JJ, Feng Y. Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China. SCAND J Clin Lab Inv. 2018;78(3):211\u20138.","journal-title":"SCAND J CLIN LAB INV"},{"issue":"3","key":"4114_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11011-019-0387-7","volume":"34","author":"Y Yan","year":"2019","unstructured":"Yan Y, Zhang C, Jin X. Mutation spectrum of PAH gene in phenylketonuria patients in Northwest china: identification of Twenty novel variants. Metab Brain Dis. 2019;34(3):733\u201345.","journal-title":"METAB BRAIN DIS"},{"key":"4114_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cca.2019.08.021","volume":"498","author":"X Wang","year":"2019","unstructured":"Wang X, He Y, Jiang Y. Screening and mutation analysis of hyperphenylalaninemia in newborns from Xiamen, China. Clin Chim Acta. 2019;498:161\u20136.","journal-title":"CLIN CHIM ACTA"},{"key":"4114_CR23","doi-asserted-by":"publisher","first-page":"1142968","DOI":"10.3389\/fgene.2023.1142968","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Fang J, Li B. Clinical and genetic characterization of pediatric patients with wilson\u2019s disease from Yunnan Province where ethnic minorities gather. Front Genet. 2023;14:1142968.","journal-title":"FRONT GENET"},{"issue":"7","key":"4114_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1515\/jpem-2021-0077","volume":"34","author":"X Yuan","year":"2021","unstructured":"Yuan X, Zhu J, Liu H. Birth prevalence of tetrahydrobiopterin deficiency in china: data from the National newborn screening program, 2013\u20132019. J Pediatr Endocr Met. 2021;34(7):835\u201341.","journal-title":"J PEDIATR ENDOCR MET"},{"issue":"2","key":"4114_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jped.2017.04.005","volume":"94","author":"C Souza","year":"2018","unstructured":"Souza C, Alves M, Soares R. BH(4) deficiency identified in a neonatal screening program for hyperphenylalaninemia. J Pediat-Brazil. 2018;94(2):170\u20136.","journal-title":"J PEDIAT-BRAZIL"},{"issue":"8","key":"4114_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/jhg.2016.38","volume":"61","author":"L Aldamiz-Echevarria","year":"2016","unstructured":"Aldamiz-Echevarria L, Llarena M, Bueno MA. Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria. J Hum Genet. 2016;61(8):731\u201344.","journal-title":"J HUM GENET"},{"issue":"1","key":"4114_CR27","first-page":"84","volume":"59","author":"P Guldberg","year":"1996","unstructured":"Guldberg P, Levy HL, Hanley WB. Phenylalanine hydroxylase gene mutations in the united states: report from the maternal PKU collaborative study. Am J Hum Genet. 1996;59(1):84\u201394.","journal-title":"AM J HUM GENET"},{"issue":"2","key":"4114_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.braindev.2020.08.012","volume":"43","author":"Y Tao","year":"2021","unstructured":"Tao Y, Han D, Shen H. Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi Province. Brain Dev-Jpn. 2021;43(2):220\u20139.","journal-title":"BRAIN DEV-JPN"},{"key":"4114_CR29","doi-asserted-by":"crossref","unstructured":"Yin C, Su K, He Z. Genetic reconstruction and forensic analysis of chinese shandong and yunnan han populations by co-analyzing y chromosomal STRs and SNPs. Genes-Basel. 2020;11(7).","DOI":"10.3390\/genes11070743"},{"issue":"6750","key":"4114_CR30","doi-asserted-by":"publisher","first-page":"eadq9792","DOI":"10.1126\/science.adq9792","volume":"388","author":"T Wang","year":"2025","unstructured":"Wang T, Yang MA, Zhu Z. Prehistoric genomes from Yunnan reveal ancestry related to Tibetans and austroasiatic speakers. Science. 2025;388(6750):eadq9792.","journal-title":"Science"},{"key":"4114_CR31","doi-asserted-by":"publisher","first-page":"1077729","DOI":"10.3389\/fgene.2022.1077729","volume":"13","author":"K Xie","year":"2022","unstructured":"Xie K, Zeng B, Zhang L. Mutation spectrum of PTS gene in patients with tetrahydrobiopterin deficiency from Jiangxi Province. Front Genet. 2022;13:1077729.","journal-title":"FRONT GENET"},{"issue":"3","key":"4114_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12519-014-0496-7","volume":"10","author":"DY Lu","year":"2014","unstructured":"Lu DY, Ye J, Han LS. QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency. World J Pediatr. 2014;10(3):219\u201326.","journal-title":"WORLD J PEDIATR"},{"issue":"1","key":"4114_CR33","doi-asserted-by":"publisher","first-page":"e211048","DOI":"10.1371\/journal.pone.0211048","volume":"14","author":"P Gundorova","year":"2019","unstructured":"Gundorova P, Stepanova AA, Kuznetsova IA. Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia. Plos One. 2019;14(1):e211048.","journal-title":"PLoS ONE"},{"issue":"1","key":"4114_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1086\/301920","volume":"63","author":"P Guldberg","year":"1998","unstructured":"Guldberg P, Rey F, Zschocke J. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet. 1998;63(1):71\u20139.","journal-title":"AM J HUM GENET"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04114-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:02:26Z","timestamp":1764072146000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04114-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4114"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04114-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Kunming Medical University. Informed consent was signed by all parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed to publish our work on this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"606"}}